Heck, M M <br/><br/>
[Compassionate use of abiraterone and cabazitaxel: first experiences in docetaxel-pretreated castration-resistant prostate cancer patients].  [electronic resource] 

 -  Der Urologe. Ausg. A  Mar 2012 
 - 390-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-0563 
<br/><br/><label>Standard No.: </label>10.1007/s00120-012-2804-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androstenes<br/>Androstenols--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Compassionate Use Trials<br/>Disease Progression<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Orchiectomy<br/>Prednisone--administration & dosage<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Taxoids--administration & dosage